| Literature DB >> 30634700 |
Weiyi Wang1, Yanyan Liao2, Beibei Zhang3, Maolin Gao4, Wenqian Ke5, Fang Li6, Zongze Shao7.
Abstract
Two previously unreported citrinin dimer derivatives, penicitol D (1) and 1-epi-citrinin H1 (2), were isolated from the culture of a deep sea-derived fungus Penicillium citrinum NLG-S01-P1, together with 11 biogenetic related compounds (3⁻13). A plausible biogenetic pathway for compounds 2⁻4 was proposed. Their structures, including absolute configurations, were established through analysis of extensive spectroscopic data and time-dependent density functional theory (TD-DFT) ECD calculations. Compounds 1 and 2 showed antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA). Compounds 5 and 10 displayed relatively stronger activities than the other compounds against Vibrio vulnificus and Vibrio campbellii. Compound 1 showed the most potent cytotoxic activity towards the HeLa cell.Entities:
Keywords: Penicillium; antibacterial; citrinin dimer; cytotoxic
Mesh:
Substances:
Year: 2019 PMID: 30634700 PMCID: PMC6357177 DOI: 10.3390/md17010046
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structure of compounds 1–13.
Figure 2Key COSY and HMBC correlations of compounds 1 and 2.
Figure 3Key NOESY correlations of compounds 1 and 2.
1H NMR data (600 MHz) and 13C NMR data (150 MHz) for compounds 1 and 2 (acetone-d6) (Figures S1, S2, S9 and S10).
| Position | 1 | 2 | ||
|---|---|---|---|---|
| δC, Type | δH, Mult. ( | δC, Type | δH, Mult. ( | |
| 1 | 58.9, CH2 | 4.54, d (15.4) | 61.3, CH | 5.29, s |
| 1 | 58.9, CH2 | 4.61, d (15.4) | ||
| 3 | 73.8, CH | 3.85, qd (6.54, 2.3) | 79.6, CH | 4.03, qd (6.5, 4.6) |
| 4 | 35.1, CH | 2.64, qd (6.87, 2.3) | 37.7, CH | 2.97, qd (7.4, 4.6) |
| 4a | 137.9, C | 140.6, C | ||
| 5 | 112.7, C | 120.1, C | ||
| 6 | 154.2, C | 156.1, C | ||
| 7 | 99.7, CH | 6.32, s | 99.6, CH | 6.61, s |
| 8 | 150.8, C | 144.9, C | ||
| 8a | 111.8, C | 111.1, C | ||
| 9 | 17.4, CH3 | 1.19, d (6.5) | 14.8, CH3 | 1.32, d (6.5) |
| 10 | 19.9, CH3 | 1.21, d (6.9) | 22.0, CH3 | 1.26, d (7.4) |
| 11 | 9.5, CH3 | 2.06, s | 10.0, CH3 | 2.17, s |
| 1′ | 170.2, C | 179.8, C | ||
| 2′ | 143.0, C | |||
| 3′ | 102.3, C | 142.3, C | ||
| 4′ | 36, CH2 | 3.09, d (18.0) | 184.8, C | |
| 4′ | 36, CH2 | 3.20, d (18.0) | ||
| 4′a | 134.5, C | |||
| 5′ | 113.4, C | 115.2, C | ||
| 6′ | 159.8, C | 149.0, C | ||
| 7′ | 100.5, C | 40.3, CH | 3.22, qd (7.3, 2.4) | |
| 8′ | 160, C | 72.3, CH | 5.48, qd (6.1,2.4) | |
| 8′a | 108.7, C | |||
| 9′ | 27.4, CH3 | 1.71, s | 20.5, CH3 | 1.34, d (7.3) |
| 10′ | 7.3, CH3 | 2.13, s | 18.3, CH3 | 1.39, d (6.1) |
| 11′ | 10.3, CH3 | 2.13, s | 11.4, CH3 | 2.14, s |
| 12′ | 160.5, CH | 7.97, s | ||
| OH-6 | 8.82, s | |||
| OH-8′ | 11.82, s | |||
| OH-8 | 7.98, s | |||
| OH-6′ | 7.82, s | |||
Figure 4Calculated and experimental ECD of compounds 1–3.
Scheme 1Postulated dimeric mechanism of 2–4.
Antimicrobial and cytotoxic activities of compounds 1–13. Data are expressed as mean ± SD values of three independent experiments, each made in triplicate.
| Compounds | MIC (μg/mL) | IC50 (μM) | |||||
|---|---|---|---|---|---|---|---|
| MRSA 1 | MRSA 2 | VV | VC | VR | A549 | HeLa | |
|
| 7.8 ± 0.8 | 7.6 ± 0.5 | NA | 30.1 ± 1.2 | NA | 23.2 ± 1.2 | 4.1 ± 0.8 |
|
| 7.3 ± 0.8 | 7.8 ± 0.9 | NA | 32.7± 1.9 | NA | 45.2 ± 0.9 | 42.3 ± 0.6 |
|
| 15.3 ± 0.6 | 15.5 ± 0.8 | NA | 32.3 ± 0.3 | NA | 46.3 ± 0.7 | 35.6 ± 0.9 |
|
| 16.3 ± 0.5 | 32.2 ± 0.3 | NA | NA | NA | 23.1 ± 0.9 | 17.7 ± 0.3 |
|
| 15.2 ± 0.4 | 16.1 ± 0.3 | 16.6 ± 0.4 | 15.3 ± 0.4 | 32.3 ± 0.3 | 40.0 ± 0.3 | 42.2 ± 0.5 |
|
| NA | NA | NA | NA | NA | NA | NA |
|
| NA | NA | 32.4 ± 0.5 | NA | 33.3 ± 0.2 | NA | NA |
|
| NA | NA | NA | NA | NA | 25.1 ± 1.0 | 27.7 ± 0.2 |
|
| NA | NA | NA | NA | 33.1 ± 0.7 | 33.1 ± 0.9 | 16.7 ± 0.1 |
|
| NA | NA | 15.7 ± 0.6 | 15.6 ± 0.5 | 32.3 ± 0.3 | 42.0 ± 0.3 | 22.2 ± 0.4 |
|
| 33.6 ± 0.2 | 32.1 ± 0.1 | NA | NA | NA | 37.7 ± 0.3 | NA |
|
| 32.1 ± 0.4 | 32.4 ± 0.1 | 32.1 ± 0.5 | NA | NA | NA | NA |
|
| NA | NA | NA | NA | 32.7 ± 0.2 | NA | NA |
| erythromycin | NT | NT | 2.0 ± 0.0 | 7.7 ± 0.2 | 3.9 ± 0.1 | NT | NT |
| chloramphenicol | 7.6 ± 0.2 | 7.5 ± 0.1 | NT | NT | NT | NT | NT |
| doxorubicin | NT | NT | NT | NT | NT | 0.1 ± 0.0 | 0.5 ± 0.1 |
MRSA 1: methicillin-resistant S. aureus ATCC 43300; MRSA 2: methicillin-resistant S. aureus CGMCC 1.12409; VV: V. vulnificus MCCC E1758; VC: V. campbellii MCCC E333; VR: V. rotiferianus MCCC E385; NA: no activity at the concentration of 50 μg/mL (antibacterial) or 50 μM (cytotoxic); NT: not tested.